Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

67 trials with published results (28%)

Research Maturity

147 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

8.0%

19 terminated out of 237 trials

Success Rate

88.6%

+2.0% vs benchmark

Late-Stage Pipeline

9%

22 trials in Phase 3/4

Results Transparency

46%

67 of 147 completed with results

Key Signals

67 with results89% success19 terminated

Data Visualizations

Phase Distribution

206Total
Not Applicable (46)
Early P 1 (1)
P 1 (43)
P 2 (94)
P 3 (15)
P 4 (7)

Trial Status

Completed147
Unknown27
Recruiting21
Terminated19
Withdrawn11
Active Not Recruiting8

Trial Success Rate

88.6%

Benchmark: 86.5%

Based on 147 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT04822181Phase 3Active Not RecruitingPrimary

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

NCT05623150Recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05720663RecruitingPrimary

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

NCT02815891Recruiting

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT04801849Phase 2Completed

Vitamin E Dosing Study

NCT07481734Phase 2Recruiting

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

NCT04302051Withdrawn

Assessment of Fatty Liver With Thermo-acoustic Device

NCT06465186Phase 2Active Not Recruiting

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT05728697Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

NCT06819917Recruiting

Identification of Liver Fibrosis Biomarkers

NCT05526144Phase 2RecruitingPrimary

Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

NCT06716905Phase 1CompletedPrimary

Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants

NCT04690972Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

NCT04666402Recruiting

Integrated Diagnostics for Early Diagnosis of Liver Disease

NCT04800094Not ApplicableCompleted

Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study

NCT04657523Not ApplicableCompleted

Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study

NCT04550481Phase 2Active Not Recruiting

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04365855Not ApplicableRecruiting

The Olmsted NAFLD Epidemiology Study (TONES)

NCT05877547Phase 2Completed

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

NCT02912260Phase 2CompletedPrimary

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Scroll to load more

Research Network

Activity Timeline